Nabil Naser

Prof. dr. - FESC, FACC, FASE, FEACVI. Polyclinic Dr. Nabil - Cardiology Department. Faculty of Medicine Sarajevo - University of Sarajevo. Bosnia & Herzegovina

[Nabil Naser @NabilNaser11]

@bosunatiklama Free Palestine.!👏👏🇵🇸🇵🇸❤️❤️

[Nabil Naser @NabilNaser11]

Nabil Naser
@NabilNaser11
·
3m
AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.” https://t.co/beq7txADMY JACC. Just Accepted. 👍🤩🤩🔥

[Nabil Naser @NabilNaser11]

@elonmuskFatZo Open your eyes.!❤️

[Victoria Delgado @VDelgadoGarcia]

Sunday morning at #3DEchoBerlin full handson on 3D echo:
🫀LV & RV quantification
❤️mitral valve analysis
💙tricuspid valve assessment
@NMerke @eromerodorta @EACVIPresident

[Nicolas Merke @NMerke]

On stage ⁦@VDelgadoGarcia⁩ at #3DEchoBerlin doing fully packed #echofirst hands on focus on MitralValve using TomTec ⁦@Philips⁩

[Nabil Naser @NabilNaser11]

@EchoSoliman @denisamuraru @echonepean @EACVIPresident @LunaGargani @Matte_Cameli @marcelohaertel @DavidWienerMD Congratulations to @EchoSoliman on an outstanding presentation on echocardiography in cardiac arrest.
Clear, practical, and truly echo-first thinking - pushing the field forward. 👏👏👏
#EchoFirst #CardiacArrest #Echocardiography #EACVI

[Nabil Naser @NabilNaser11]

@alex1708ander PISA reflects flow acceleration driven by a high pressure gradient (ΔP).
MR (LV→LA): high ΔP → true convergence zone.
ASD: low LA–RA ΔP + compliant RA → flow disperses, (no true convergence zone) → no true PISA
Color Doppler = flow, not acceleration.
#EchoFirst #CardioTwitter

[Nabil Naser @NabilNaser11]

@lpbadano @Drbernardourru1 @NMerke @jaumeaguero @echo_stepbystep @dr_benoy_n_shah @iamritu @alex1708ander @AHagendorff @dhzcharite Agreed. The apparent advantage seems driven by LV volume accuracy, not VM itself. 3D LV volumes improve prognostic performance, but feasibility, time, and availability still limit routine adoption—where 2D remains dominant.
#3DEcho #EACVI #EchoFirst #ValveDisease

[Nabil Naser @NabilNaser11]

Kudos to @EACVIPresident, @NAjmoneMarsan, @DrMarkWestwood1 and Dr Marc Dweck for a fantastic #EACVI 2025 and an outstanding scientific program. Impressive attendance, great engagement, and excellent discussions throughout. An honor to be part of this amazing event! 👏❤️👏

[Nabil Naser @NabilNaser11]

@argulian The most likely reason for the low TAPSE and s’ measurement is a technical artifact due to a foreshortened apical four-chamber view.

[EACVI President @EACVIPresident]

💥 Late Registration is STILL Open! | #EACVI2025 💥

Did you miss the early bird deadline? Don’t worry — there’s still time! ���✨

Join leading cardiovascular imaging experts from around the world at #EACVI2025, the premier event that merges the strengths of #EuroEcho #ICNCCT & #EuroCMR
#EACVI 2025 ensures that each imaging discipline retains its specificities while contributing to a collective vision for patient-centred, multimodal care.

📍 Location: Vienna
📅 Dates: 11-13 December
🕒 Late registration closes soon – secure your spot now!

🔗 Register here: https://t.co/SdibrVHDjU

[Nabil Naser @NabilNaser11]

@denisamuraru Congratulations, dear Denisa! 🎉
A truly well-deserved recognition of your outstanding contributions to echocardiography. Your dedication, leadership, and impact continue to inspire colleagues worldwide. Honored to see your work celebrated by the BSE. 👏❤️🌍

[Nabil Naser @NabilNaser11]

Two decades ago, reaching lipid goals was aspirational.
Now it’s achievable with statin, ezetimibe, bempedoic acid, PCSK9 inhibitors, siRNA & personalized care.
But when is the right time to choose the optimal LLT strategy?🤔😎🤔
#CardioHealth #LipidManagement

[Aniela Popescu (Petrescu) @aniela_petrescu]

What do the guidelines recommend in the treatment of mitral valve regurgitation?
@VDelgadoGarcia presenting at the Valvular Heart Disease Forum in Bucharest, Romania
@EACVIPresident

[Nabil Naser @NabilNaser11]

@nadaa01012 🇵🇸🍉

[Nabil Naser @NabilNaser11]

@EchoSoliman @EACTAIC @AleksandarNesk6 @LunaGargani @fabiodoc64 @ViaWINFOCUS @EACVIPresident @VDelgadoGarcia @denisamuraru @iamritu @escardio @DavidWienerMD Congratulations, dear Hatem 👏 ❤️👏 on this outstanding achievement. An excellent contribution to the field of emergency and critical care echocardiography, and a great milestone for EACVI collaboration.

[Nabil Naser @NabilNaser11]

@arisaqz1 YES

[Nabil Naser @NabilNaser11]

New 2025 #ACC #AHA #ACEP #NAEMSP #SCAI Guideline on Acute Coronary Syndromes just released!

🔑 DAPT ≥12 mo (if not high bleeding risk)
🔑 Radial access PCI preferred
🔑 High-intensity statin for all ACS
🔑 Cardiac rehab referral
👉 Full text:https://t.co/CapO7QLcYw

[EACVI President @EACVIPresident]

The #EACVI2025 Scientific Programme is packed with hands-on sessions, expert-led tracks & real-world science you can apply in clinic.
✅ All major modalities
✅ CME credits
✅ Skills you can use now

Explore debates, reviews, guidelines & more. Register early to save!

🔗 https://t.co/vR54ATkvYW

@denisamuraru @s_e_petersen @NAjmoneMarsan @rmanka_ @DrMarkWestwood1 @papadocardio @hahn_rt @dr_benoy_n_shah @senguptasp @AnnaSannino1985 @Cosyns @ThorEdvardsen @bogdan_popescu1 @gpontone1 @PalMaurovich @WilliamZoghbi @VDelgadoGarcia

[Nabil Naser @NabilNaser11]

@escardio @EACVIPresident @FabienPraz The 2025 #ESC #EACTS #VHD Guidelines rightly emphasize structured Heart Valve Centers and precise timing of interventions-critical for advancing patient outcomes and procedural excellence. #ESCGuidelines #TAVI #MitralValve